During this webinar, Thomas Hanke, EVP Head of Academic Partnerships at Evotec in Germany, will present his vision and experience on how the preclinical validation of translational academic research projects should be planned and executed, in relationship with its foreseen clinical applications.
Evotec is a biotechnology company that offers technological expertise to advance drug discovery and development in a co-creation model with pharmaceutical companies, biotechs, foundations, and government agencies; as well as CRO/CDMO services for the Biopharma R&D sector.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Starting or changing any procedure at a TTO/Institution is challenging and I could not think of anything better than learning with the best.
Ricardo Castro
Centre for research in agricultural Genomics, Spain
Most relevant, interesting and practical training I have ever had, very interactive an multi-disciplinary. It makes an IMPACT.
Edith van Lishout
KU Leuven, Belgium
A must-do for any staff involved in technology transfer and start-up creation.
Frederic Ratel
Institute of Chemical Research of Catalonia, Spain
I had a great experience and met high profile professionals.
Antonio Menegatti
Politecnico di Milano, Italy
Organisation and speakers were great, so enthusiastic about their work and very good at transferring their knowledge.
Sarka Bartova
Research Centre Rez, Czech Republic
Join our newsletter and get the latest news